
Australian needle-free vaccine start-up raises $23m

OneVentures and UniQuest have led a AUD 34m (USD 23m) funding round for Vaxxas, an Australia-based biotechnology company running clinical programmes that include a needle-free COVID-19 vaccine candidate.
The company’s core technology was initially developed at the University of Queensland and Vaxxas was established in 2011 by UniQuest, the university’s commercialisation unit. OneVentures was also...
Latest News
Monolith sets $250m hard cap for China fund
Monolith Management, an investment firm established by Xi Cao, formerly a partner at Sequoia Capital China, has set the hard cap at USD 250m for its debut China venture capital fund.
Adamantem buys Australia's Retail Zoo from Bain
Adamantem Capital has acquired a majority stake in Retail Zoo, operator of Australia-headquartered food retail brands Boost Juice and Betty’s Burgers, from Bain Capital for an undisclosed sum.
Carlyle names Harvey Schwartz as CEO
The Carlyle Group has appointed Harvey M. Schwartz, formerly president and co-COO of Goldman Sachs, as its new CEO.
AVCJ Awards 2022: Deal of the Year – Large Cap: Crown Resorts
Crown Resorts represented a daunting target, given its size and pandemic and regulatory-related challenges. The Blackstone Group drew on its global know-how to make the USD 8.1bn deal work